Once-a-day Tacrolimus Conversion Study: The OneTAC Trial
NCT02545972
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure
Interventions
DRUG:
tacrolimus extended release
Sponsor
Newark Beth Israel Medical Center